Computed Tomography (CT) is an essential tool in clinical diagnosis, but its effectiveness depends heavily on the dynamic selection of imaging phases: non-contrast, arterial, venous, etc. This decision, based on preliminary findings and clinical guidelines, aims to minimize radiation exposure and accelerate patient staging. However, protocols vary among hospitals, regions, and regulations, and current artificial intelligence (AI) systems often assume all phases are available, limiting their real-world applicability. This is where PD-CTAgent emerges—an intelligent agent designed to select CT phases dynamically and rationally.
PD-CTAgent (Policy-Driven CT-Agent) introduces two key components. The first is the Clinical Structure Abstraction Module (CSAM), which unifies heterogeneous representations from different phases into a common phase-aware space. The second is the Knowledge-Guided Diagnostic Control Model (KDCM), which evaluates whether the available information is sufficient for a reliable diagnosis and, if not, requests additional phases. This policy-based approach allows adaptation to different institutional or regional protocols, overcoming the rigidity of static models.
From a business perspective, adopting agents like PD-CTAgent represents an opportunity to transform workflows in imaging diagnostics. Healthcare organizations can benefit from custom AI solutions that optimize decision-making and reduce the burden on radiologists. At Q2BSTUDIO, we develop custom software that integrates machine learning models, artificial intelligence, and process automation for clinical environments. Combining AI agents with cloud platforms such as AWS or Azure allows these systems to scale securely and efficiently, ensuring regulatory compliance and protection of sensitive data.
Cybersecurity is another fundamental pillar in handling patient data. Any AI system applied to CT must comply with standards like HIPAA or GDPR. Therefore, at Q2BSTUDIO we offer cybersecurity services to audit and protect critical infrastructures. Additionally, incorporating Business Intelligence (BI) with Power BI enables clinical teams to visualize phase usage patterns, diagnostic effectiveness, and response times, facilitating continuous protocol improvement.
Developing agents like PD-CTAgent not only improves diagnostic accuracy but also reduces unnecessary radiation and operational costs. By delegating phase decisions to an agent trained on multiple data sources, radiologists can focus on complex cases while the system handles routines. This is Q2BSTUDIO's vision: creating custom software that combines AI, cloud, and data analytics to solve real-world problems in the healthcare sector.
On the technical side, PD-CTAgent uses reinforcement learning and clinical graph representations to model relationships between phases. CSAM transforms images from different phases into a unified format, while KDCM acts as a controller deciding whether the evidence is sufficient. This approach has been validated on public datasets such as LIDC and MCT-LTDiag, and on a private dataset, demonstrating clinical consistency and flexibility across different guidelines.
For health-tech companies, investing in such developments provides a competitive advantage. Customizing agents according to local protocols (European, American, Asian) is possible thanks to the policy-based architecture. Q2BSTUDIO collaborates with hospitals and research centers to adapt these solutions, integrating cloud services (AWS/Azure) that ensure high availability and scalability. Likewise, process automation through AI agents reduces human intervention in repetitive tasks, improving overall efficiency.
The application of PD-CTAgent is not limited to CT diagnostics. Its principles—dynamic information selection, knowledge-guided reasoning, and policy adaptation—can extend to other medical imaging modalities or even to fields like industrial diagnostics or security. In all these areas, combining custom software applications with AI and cloud is key to building reliable and efficient systems.
In conclusion, PD-CTAgent represents a significant step toward smarter and clinically consistent CT diagnostics. Integrating AI agents into daily practice not only improves patient outcomes but also optimizes hospital resources. At Q2BSTUDIO, we are committed to software development that drives this transformation, offering personalized solutions in AI, cybersecurity, cloud, and BI. If your organization is looking to implement dynamic phase selection systems or any other cutting-edge technology, do not hesitate to contact us.
